Trusted Resources: Education
Scientific literature and patient education texts
Molecular Analysis of Vietnamese Patients With Mucopolysaccharidosis Type I
source: Life (Basel, Switzerland)
year: 2021
authors: Can NTB,Tran DM,Bui TP,Nguyen KN,Nguyen HH,Nguyen TV,Hwu WL,Tomatsu S,Vu DC
summary/abstract:Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder caused by deleterious mutations in the α-L-iduronidase () gene. Until now, MPS I in Vietnamese has been poorly addressed. Five MPS I patients were studied with direct DNA sequencing using Illumina technology confirming pathogenic variants in the gene. Clinical characteristics, additional laboratory results, and family history were collected. All patients have presented with the classical characteristic of MPS I, and α-L-iduronidase activity was low with the accumulation of glycosaminoglycans. Three variants in the gene (c.1190-10C>A (Intronic), c.1046A>G (p.Asp349Gly), c.1862G>C (p.Arg621Pro) were identified. The c.1190-10C>A variant represents six of the ten disease alleles, indicating a founder effect for MPS I in the Vietnamese population. Using biochemical and genetic analyses, the precise incidence of MPS I in this population should accelerate early diagnosis, newborn screening, prognosis, and optimal treatment.
organization: Vietnam National Children's Hospital, 18/879 Lathanh, Dongda, Hanoi 100000, Vietnam.DOI: 10.3390/life11111162
read more
Related Content
-
Emotional Responses to Diagnosis of MPS or MLIf you or someone you know have been dia...
-
Mucopolysaccharidoses Fact SheetThe mucopolysaccharidoses are a group of...
-
A 22 Year Old Rotherham Man, no Longer Walk Up His StairsA Yorkshire community has launched a fun...
-
Mucopolysaccharidoses Type I Gene TherapyMucopolysaccharidoses type I (MPS I) is ...
-
Stem Cell Transplant for Bridgnorth Boy With Rare ConditionTwenty-two-month-old Gunner, from Bridgn...
-
CHOC-Harbor UCLA MPS Multidisciplinary CenterCHOC and Harbor-UCLA Pediatrics together...
-
Mucopolysaccharidoses Diagnosis in the Era of Enzyme Replacement Therapy in EgyptUndegraded glycosaminoglycans (GAGs) ind...